OOIR: Observatory of International Research

Papers

(The median citation count of Experimental Hematology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
RNA methylation: where to from here for hematologic malignancies?	42
3131 – DISPARITIES IN IMMUNOSUPPRESSIVE PROFILES BETWEEN RELAPSED AML WITH OR WITHOUT ALLO-HCT	32
3008 – INTEGRATED IN SILICO AND IN VITRO APPROACHES MATCH DEVELOPMENTAL CELL-OF-ORIGIN TO THERAPEUTIC VULNERABILITIES IN INFANT LEUKEMIA	30
3127 – INDUCTION OF ONTOGENY-SPECIFIC CD24+ PRELEUKEMIC STEM CELLS IN A KMT2A::AFF1 MURINE MODEL	28
3055 – THE 3′ DISTAL ENHANCER REGION OF THE CEBPB GENE IS ESSENTIAL FOR MONOCYTE DEVELOPMENT	27
3133 – UNCOVERING DISTINCT METABOLIC PROPERTIES OF RELAPSE AND RELAPSE-FATED CLONES IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA	24
Distinct transcriptional changes in hematopoietic progenitor subsets on LPS-induced emergency granulopoiesis	23
2019 – DURING AGEING, THE HEMATOPOIETIC STEM CELL GENOME IS PROTECTED BY DORMANCY, NOT APOPTOSIS.	22
3116 – MITOCHONDRIAL FUSION AGONISTS IMPROVE EXPANDED CORD BLOOD HEMATOPOIETIC STEM AND PROGENITOR CELLS FUNCTION IN VIVO	20
3016 – MYCT1 CONTROLS HUMAN HEMATOPOIETIC STEM CELL FUNCTION BY MODERATING ENDOCYTOSIS AND ENVIRONMENTAL SENSING	19
3059 – UNRAVELLING HUMAN HEMATOPOIETIC PROGENITOR CELL DIVERSITY THROUGH ASSOCIATION WITH INTRINSIC REGULATORY FACTORS	19
RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs	18
3033 – DIFFERENTIAL RESPONSES AND RECOVERY DYNAMICS OF HAEMATOPOIETIC POPULATIONS FOLLOWING PLASMODIUM CHABAUDI INFECTION	17
Corrigendum to A novel lymphoid progenitor cell population (LSKlow) is restricted by p18INK4c Experimental Hematology Volume 44 Issue 9 (2016), 874-885.e5	17
Neutrophil death-more than meets the eye	17
Corrigendum to ’ 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9’ [Volume 114, October 2022, Pages 43-53.e2]	17
1022 – ADVANCES IN CELLULAR BARCODING: EXPLORING HEMATOPOIETIC STEM CELLS AGEING AND METABOLIC FUNCTIONS IN LINEAGE SPECIFICATION	16
1007 – GENOMIC REPETITIVE ELEMENTS SIGNAL SURFACE B2M TO BLOCK PHAGOCYTOSIS OF HSCS	16
3215 – TWO NOVEL ENHANCERS OF CDKN1A ARE EPIGENETICALLY REGULATED BY THE CHROMATIN ASSEMBLY FACTOR 1 AND CEBPA IN ACUTE MYELOID LEUKEMIA	14
3194 – CLONAL HEMATOPOIESIS-ASSOCIATED DNMT3A MUTATIONS CAUSE INCREASED T CELL ACTIVATION AND DECREASED LEUKEMIC TUMOR BURDEN	14
IFC Editorial Board	14
Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage	13
3060 – BONE MARROW MESENCHYMAL STEM CELLS RELY ON VASCULAR CELL ADHESION MOLECULE-1 FOR SURVIVAL AND NICHE MAINTENANCE	13
1030 – CELLULAR AND MOLECULAR MECHANISMS OF HEMATOPOIETIC LINEAGE CHOICE	13
Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtypes	12

3064 – ALKBH5 MODULATES HEMATOPOIETIC STEM AND PROGENITOR CELL ENERGY METABOLISM THROUGH M6A MODIFICATION-MEDIATED RNA STABILITY CONTROL	12
3185 – A MACHINE LEARNING PIPELINE UNCOVERS LAG-3-MEDIATED IMMUNOREGULATION IN INFLAMMATORY HSCs	12
3144 – GRX1 DEGLUTATHIONYLATES NF-κB P65 TO INCREASE LAG3 EXPRESSION IN T CELLS AND PROMOTE TUMOR GROWTH	12
ZC3H13 facilitates the progression of acute myeloid leukemia through m6A-FOXP1-mediated metabolic reprogramming	12
1006 – HEMATOPOIETIC STEM CELL ACTIVATION FOR BLOOD REGENERATION	11
2015 – MENIN ORCHESTRATES EXPRESSION OF THE MASTER PLASMA CELL TRANSCRIPTION FACTOR IRF4 AND IS AN ACTIONABLE TARGET IN MULTIPLE MYELOMA.	11
3218 – LYL1 IS CRITICAL FOR ADULT HEMATOPOIETIC STEM CELL-DERIVED B- AND T-LYMPHOPOIESIS	11
3089 – AN ITGB3 CYTOPLASMIC MUTATION CAUSES MACROTHROMBOCYTOPENIA VIA IMPAIRED αIIBβ3–RHOA SIGNALING	11
1005 – MAPPING THE DEVELOPMENTAL PATHWAYS TO HUMAN HEMATOPOIETIC AND LEUKEMIC STEM CELLS	11
3129 – PREEMPTIVE TARGETING OF PRELEUKEMIC CELLS IN DOWN SYNDROME WITH PATHWAY-DIRECTED THERAPIES: A NOVEL APPROACH TO PREVENT MYELOID LEUKEMIA	11
3004 – IN VITRO EXPANDED HEMATOPOIETIC STEM CELLS COMBINED WITH NON-GENOTOXIC CONDITIONING ENABLE EFFICIENT TRANSPLANTATION AND SUPPRESS MYELOID DISEASE	11
3138 – LIMS1 REGULATES ACUTE MYELOID LEUKEMIA INITIATION THROUGH CELL ADHESION INTERACTIONS AND MIGRATION OF LEUKEMIC STEM CELLS	11
3085 – THERMAL PROTEOME IDENTIFIES KEY REGULATORS IN HEMATOPOIETIC STEM CELLS	11
Ontogeny, dynamics, and characteristics of neutrophils during the perinatal period	10
Building bones for blood and beyond: the growing field of bone marrow niche model development	10
Effect of peritransplant measurable residual disease clearance in patients with myelodysplastic neoplasm: a referral center experience	10
3187 – MECOM PROMOTES LEUKEMIA PROGRESSION AND INHIBITS MAST CELL DIFFERENTIATION THROUGH FUNCTIONAL COMPETITION WITH GATA2	10
Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis	10
Gene regulatory complexes: their role and regulation across normal and malignant hematopoiesis	10
Cover 2: Editorial Board	10
2024 – UNDERSTANDING HOW THE TISSUE MICROENVIRONMENT DIRECTS CELL FATE IN HAEMATOPOIETIC STEM AND PROGENITOR CELLS	9
3124 – ANALYSIS OF TRANSCRIPTOMIC AND EPITRANSCRIPTOMIC EFFECTS OF THE ACUTE MEGAKARYOBLASTIC LEUKEMIA FUSION PROTEIN RBM15-MKL1	9
3220 – THE BONE MARROW EXTRACELLULAR MATRIX REMODELLING DURING ACUTE MYELOID LEUKAEMIA	9
3174 – DOWNREGULATION OF MITOCHONDRIAL COMPLEX II IN MYELODYSPLASTIC SYNDROMES	9
JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms	9
Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond–Blackfan anemia	9
3069 – EXPANSION OF A NOVEL LEUKEMIA STEM CELL-SUPPORTING CD55+ FIBROBLAST POPULATION IN THE PRELEUKEMIC BONE MARROW	9
3141 – METABOLIC PROFILING OF HEMATOPOIETIC STEM CELLS (HSCS) FOLLOWING ACUTE INFLAMMATION	9
3110 – EGFL7 IS IMPORTANT FOR CELL CYCLE REGULATION AND PROLIFERATION OF HSCS	9
2016 – CD32 ALLOWS CAPTURING BLOOD CELLS EMERGENCE IN SLOW MOTION DURING HUMAN EMBRYONIC DEVELOPMENT	8
3055 – MULTI-OMICS REVEALS AZACITIDINE PARTIALLY RESTORES THE HEMATOPOIESIS-SUPPORTIVE FUNCTIONS IN MESENCHYMAL STROMAL CELLS FROM PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA	8
3054 – MESENCHYMAL STEM CELLS REVERSIBLY DE-DIFFERENTIATE MYOFIBROBLASTS TO FIBROBLAST-LIKE CELLS BY INHIBITING THE TGF-Β-SMAD2/3 PATHWAY	8
Cover 2: Editorial Board	8
3131 – CROSS-SPECIES TRANSCRIPTOMICS REVEALS BIFURCATION POINT DURING THE ARTERIAL-TO-HEMOGENIC TRANSITION	8
Reproducibility of low-level residual myeloma immunoglobulin detection using ultra-deep sequencing	7
A new era of functional experimentation in human hematopoiesis and leukemia research	7
3097 – THE LONG NONCODING RNA ELDR AS A NEW THERAPEUTIC TOOL AGAINST HUMAN ACUTE MYELOID LEUKEMIA (AML)	7
3108 – PHOSPHORYLATION OF RUNX1 PROMOTES MEGAKARYOCYTIC FATE IN MEGAKARYOCYTE-ERYTHROID PROGENITOR FATE SPECIFICATION	7
3192 – DEFINING THE MECHANISMS OF BST2 IN INFLAMMATION-DEPENDENT HEMATOPOIETIC STEM CELL ACTIVATION	7
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy	7
3057 – MULTIOME ANALYSIS IDENTIFIES HSC SUBSETS WITH THYMIC REGENERATIVE CAPACITY	7
3168 – TARGETING JAK1 SIGNALING FOR MOLECULAR PREVENTION IN CLONAL HEMATOPOIESIS	7
3073 – EARLY IDENTIFICATION OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE BY F-DEX ASSAY AND MURINE MODELS	7
2004 – INFLAMMATORY FACTORS ORCHESTRATE THE BIRTH OF HSPCS THROUGH THEIR OSCILLATORY SIGNALING DYNAMICS	7
Endogenous small molecule effectors in GATA transcription factor mechanisms governing biological and pathological processes	7
3011 – UNIQUE ROLES OF KMT2A FAMILY MEMBERS IN HEMATOPOIESIS AND LEUKEMIA	7
3043 – FETAL EMERGENCY MYELOPOIESIS IS RESTRICTED BY MATERNAL INFLAMMATION.	7
2008 – SELF-RENEWAL OF LATE-STAGE ERYTHROID PROGENITORS	7
Preconditioning intervention prior to allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia	6
3042 – PRECISE INTRODUCTION OF SRSF2 P95H RECAPITULATES DISEASE PHENOTYPES AND GIVES INSIGHT INTO THE CELLULAR MECHANISM OF ACTION	6

3110 – EX VIVO CRISPR-BASED SICKLE CELL MODELING	6
Immune control in acute myeloid leukemia	6
3193 – THE FUNCTIONAL ROLE OF NUCLEAR PROTEIN 1 (NUPR1) IN AGE-RELATED HEMATOPOIETIC STEM CELL FATE PRIMING	6
3187 – INVESTIGATION OF THE THERAPEUTIC EFFECT OF A NOVEL SMALL MOLECULE INHIBITING YBX1 IN MYELOID MALIGNANCIES	6
3027 – CASEIN KINASE II ALPHA (CK2A) DELETION AFFECTS MYELOID HEMATOPOIESIS IN CONDITIONAL KNOCKOUT MOUSE MODEL	6
3052 – PLZF LOSS-OF-FUNCTION ALTERS THE HEMATOPOIETIC STEM CELL COMPARTMENT IN AN AGE-DEPENDENT MANNER	6
3190 – ACCOUNTING FOR BIOLOGICAL VARIATION IN SCRNA-SEQ QUALITY CONTROL METRICS RETAINS DISTINCT NICHE AND HEMATOPOIETIC CELL TYPES	6
Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis	6
Inhibition of PAK1 generates an ameliorative effect on MPLW515L mouse model of myeloproliferative neoplasms by regulating the differentiation and survival of megakaryocytes	5
TET2 loss enhances early response to inflammation in primitive and committed myeloid cells	5
3213 – DISSECTING THE BLOOD ECOSYSTEM IN SARS-COV-2 OMICRON PATIENTS	5
3119 – IDENTIFICATION OF CULTURE CONDITIONS THAT SUSTAIN THE IN VIVO REGENERATIVE PROPERTIES OF A NEW SUBSET OF HUMAN FETAL LIVER HEMATOPOIETIC STEM CELLS	5
3151 – PUTTING THE STING BACK INTO THERAPY FOR P53 MUTANT BLOOD CANCERS	5
3136 – RAMAN SPECTROSCOPY IMAGING TO TRACK ACTIVITY OF IMMUNE CELLS.	5
3082 – SECRETOMIC CHARACTERIZATION OF REVITALIZED BONE MARROW STROMAL CELLS IDENTIFIES SEMAPHORIN 3A AS A NICHE FACTOR THAT REGULATES HSC QUIESCENCE	5
1024 – NICOTINAMIDE RIBOSIDE ENHANCES AMINO ACID CATABOLISM TO REJUVENATE OLD HEMATOPOIETIC STEM CELLS BY RESTORING THEIR METABOLISM AND PROTEOSTASIS	5
Development and aging of resident endothelial stem cells in pre-existing blood vessels	5
In Memoriam: Prof. Vittorio Rizzoli, The visionary who built experimental hematology in Italy	5
Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study	5
3122 – CUX1 LEVELS CONTROL HEMATOPOIETIC STEM CELL FATE AND PLASTICITY	5
2006 – RAS MUTATIONS TRANSFORM GRANULOCYTE-MONOCYTE PROGENITORS INTO INFLAMMATORY LEUKEMIA STEM CELLS IN ACUTE MYELOID LEUKEMIA	5
Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV	5
1002 – BONE MARROW FAILURE AND CLONAL EVOLUTION	5
Analysis of risk factors for early death of lymphocyte subsets in adult patients with secondary hemophagocytic lymphohistiocytosis	5
Generation of functionally distinct hemogenic endothelial cell populations from pluripotent stem cells	5
3120 – INVESTIGATING THE ROLE OF GPR56 IN ACUTE MYELOID LEUKAEMIA USING A TET-ON MODEL OF AN ACTIVATED GPR56 RECEPTOR IN HUMAN IPSC-DERIVED HAEMATOPOIETIC CELLS	5
3163 – ANTI-CD69 MONOCLONAL ANTIBODY AVENUE DISEASE PROGRESSION IN A MOUSE MODEL OF CHRONIC MYELOMONOCYTIC LEUKEMIA WITH NRASG12D MUTATION	5
Functional and molecular profiling of hematopoietic stem cells during regeneration	5
Glucose-6-phosphate dehydrogenase is dispensable for human erythroid cell differentiation in vitro	5
3128 – IDENTIFICATION AND CHARACTERIZATION OF CD96+CD70+ LEUKEMIC STEM CELLS AND NICHE-MEDIATED RESISTANCE IN CBFA2T3-GLIS2 AMKL	5
Fetal allotransplant recipients are resistant to graft-versus-host disease	4
AKT2 inhibition accelerates the acquisition of phagocytic ability in induced pluripotent stem cell–derived neutrophils	4
3003 – MASS SPECTROMETRY-BASED PROFILING OF BONE MARROW NICHE SECRETOME REMODELING IN AGING AND TET2-MUTANT CLONAL HEMATOPOIESIS	4
Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells	4
2004 – A SINGLE-CELL PROTEOMICS BY MASS SPECTROMETRY BASED MAP OF THE HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELL COMPARTMENT	4
3086 – THE ROLE OF DEVELOPMENTAL WNT SIGNALING IN ABERRANT ADULT HEMATOPOIESIS	4
2023 – INTRA- AND EXTRACELLULAR PROTEOME DYNAMICS DURING NORMAL AND MALIGNANT HEMATOPOIETIC STEM CELL EXPANSION	4
1032 – STEM CELLS IN HUMAN AML	4
1024 – A GENETIC LABELING STRATEGY FOR COMPETITIVE XENOTRANSPLANTATION OF HUMAN HSCS	4
3021 – EX VIVO EXPANSION OF HEMATOPOIETIC PROGENITOR CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS	4
Mtg16 NHR1 mutations cause defects in lymphopoiesis and the response to anemia	4
3029 – ISOFORM SPECIFIC ROLES FOR CD97 IN ACUTE MYELOID LEUKEMIA	4
Effects of ruxolitinib on murine regulatory T cells are immune-context dependent	4
3097 – CLONAL COMPETITION, FITNESS, AND MUTATION TIMING DRIVE ADVERSE OUTCOMES IN CLONAL HEMATOPOIESIS	4
3221 – KLF4/MLL3 CAMPASS COMPLEX TRANSCRIPT REGULATING NRBP2 TO ELIMINATE AML CELLS	4
3076 – EARLY MYELOID COMMITMENT OF HSCS: MAFB AS A MASTER REGULATOR?	4
3198 – IGH TRANSLOCATIONS IN CHINESE PATIENTS WITH CHRONIC LYMPHOCYTICLEUKEMIA: CLINICOPATHOLOGIC CHARACTERISTICS AND GENETIC PROFILE	4
3109 – IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A::AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA	4
Inflammation-related mRNA expression in patients with multiple myeloma undergoing hematopoietic stem cell mobilization	4
C-COUNT: a convolutional neural network–based tool for automated scoring of erythroid colonies	4
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice	4
3173 – HAPLODEFICIENCY OF THE MTAP/CDKN2 LOCUS DRIVES IMMUNOMETABOLIC DYSREGULATION AND STROMAL CELL ALTERATIONS LEADING TO MYELODYSPLASTIC SYNDROMES-LIKE DISEASE	4
1004 – REGULATION OF THE HEMATOPOIETIC STEM CELL POOL BY C-KIT-ASSOCIATED TROGOCYTOSIS	4
3044 – IDENTIFICATION OF SURFACE MARKERS OF MALIGNANT CELL STATES IN ACUTE MYELOID LEUKEMIA USING EXPLAINABLE MACHINE LEARNING	4
3076 – CHARACTERIZATION OF THE ROLE OF EIF4A IN THE RESISTANCE OF ACUTE MYELOID LEUKEMIA TO CHEMOTHERAPY AND TARGETED THERAPIES	4
Presence of mutant p53 increases stem cell frequency and is associated with reduced binding to classic TP53 binding sites in cell lines and primary AMLs	4
3180 – SRSF2 P95H AND NF1 DEFICIENCY SYNERGIZE TO PROMOTE MYELOID-BIASED CLONAL HEMATOPOIESIS FROM HEMATOPOIETIC STEM CELLS VIA JAK-STAT ACTIVATION IN MICE	4
TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells	3
3018 – DETERMINING THE VARIATIONS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN CANCER PATIENTS - A PROSPECTIVE STUDY	3
1016 – FINE-TUNING TPO-MPL ACTIVITY TO CONTROL HEMATOPOIESIS	3
3068 – N-MYC EXPRESSION IS NEGATIVELY CORRELATED WITH SELF-RENEWAL POTENTIAL IN HSCS	3
3177 – CLONAL HEMATOPOIESIS PROMOTES HEART FAILURE WITH PRESERVED EJECTION FRACTION	3
1018 – MALPS: A MASTER REGULATOR OF BONE MARROW MICROENVIRONMENT	3
3036 – AUTOPHAGY REGULATES THE MATURATION OF HEMATOPOIETIC PRECURSORS IN THE EMBRYO	3
3027 – IDENTIFYING PIONEER FACTORS DURING HEMATOPOIETIC STEM CELL EMERGENCE	3
3151 – THE ALTERNATIVE NUCLEOSOME REMODELING FACTOR COMPLEX SUSTAINS ACUTE MYELOID LEUKEMIA BY REGULATING THE ACCESSIBILITY OF INSULATOR REGIONS	3
3178 – FANCONI ANEMIA PROTEIN FANCD2 REGULATES FETAL LIVER HEMATOPOIETIC STEM CELL EXPANSION IN A CELL-INTRINSIC AND EXTRINSIC MANNER	3
A-to-I RNA editing and hematopoiesis	3
Assay optimization for the objective quantification of human multilineage colony-forming units	3
1008 – UNIFIED SINGLE-CELL METHODS SORT DIVERGENT FATES THROUGH GENE REGULATION	3
3012 – DEEPLY QUIESCENT HEMATOPOIETIC STEM CELLS MAINTAIN FUNCTION BY GPRASP2-MEDIATED CELL-SURFACE RECEPTOR DEGRADATION	3
3201 – HEMATOPOIETIC STEM CELL-DERIVED CAR-IMMUNE SYSTEM FOR TUMOR IMMUNOTHERAPY	3
Cover 2: Editorial Board	3
3075 – DNMT3A LIMITS MYELOID SIGNALING RESPONSES IN T-CELL PROGENITORS DURING NORMAL AND LEUKEMIC DEVELOPMENT	3
IFC Editorial Board	3
3068 – CRISPR SCREENING IN PRIMARY HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS IDENTIFIES THE RNA HELICASE DDX6 AS A NOVEL HSC REGULATOR	3
2012 – DENDRITIC CELLS IN DEVELOPING AND ADULT ZEBRAFISH ARISE FROM DIFFERENT ORIGINS AND DISPLAY DISTINCT FLT3 DEPENDENCIES	3
3018 – THE BILE ACID RECEPTOR TGR5 REGULATES THE COMPOSITION AND HEMATOPOIETIC SUPPORT CAPACITY OF THE BONE MARROW MICROENVIRONMENT	3
2024 – A STEP-WISE AND DETERMINISTIC LEUKEMIA MOUSE MODEL REMINISCENT OF JMML WITH ENDOGENOUS ACQUISITION OF PATIENT-RELEVANT RTK–RAS MUTATIONS	3
Cell-extrinsic factors contribute toward myeloid-biased expansion in Tet2-mutant clonal hematopoiesis	3

Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34+ Hematopoietic Stem Cells	3
2011 – SUBCLONAL MUTATIONS ALTER CORE SIGNALLING NODES AND DRUG RESPONSES IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA	3
1007 – MAXIMIZING CELL DEATH IN LEUKEMIAS: BCL-2 AND BEYOND	3
2023 – CELLULAR BARCODING OF THE LEUKEMIC NICHE REVEALS AN APELIN-MEDIATED CLONAL EXPANSION OF NICHE ENDOTHELIAL AND MESENCHYMAL STROMAL CELLS	3
3177 – RUNX FACTORS LAUNCH T CELL AND INNATE LYMPHOID CELL PROGRAMS VIA DIRECT BINDING AND GENE NETWORK-BASED MECHANISMS	3
1005 – SWITCHING GENES ON AND OFF DURING HAEMATOPOIESIS	3
3171 – GLYCOLYSIS DRIVES IL-6 PRODUCTION BY BONE MARROW STROMAL CELLS DURING ACUTE INFLAMMATION	3
3048 – DISSECTING THE HETEROGENEITY OF EX VIVO EXPANDED HEMATOPOIETIC STEM AND PROGENITOR CELLS WITH MICRORNAS	3
3056 – DNMT3A MUTATIONS UPREGULATE CELL ADHESION MOLECULES TO PROMOTE INVASIVENESS OF T-ALL CELLS	3
3246 – DEVELOPMENTAL AND FUNCTIONAL ANALYSIS OF MONOCYTES AND MACROPHAGES IN ZEBRAFISH DURING HEART REGENERATION	3
Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer	3
3001 – PCYT1A IS A METABOLIC VULNERABILITY IN MONOCYTIC ACUTE MYELOID LEUKEMIA	3
Sustained MYC overexpression drives myeloid differentiation block and acquisition of leukemic phenotypes	3
3139 – THE ROLE OF MYELOID CELLS HARBORING CLONAL HEMATOPOIESIS MUTATIONS IN ALZHEIMER'S DISEASE	2
Cover 2: Editorial Board	2
2009 – WORLD TRADE CENTER 9/11 DISASTER EXPOSURE IS ASSOCIATED WITH CLONAL HEMATOPOIESIS IN FIRST RESPONDERS AND IS CHARACTERIZED BY INNATE IMMUNE INFLAMMATION.	2
3145 – SINGLE-CELL RNA SEQUENCING REVEALS GATA3 REGULATES DIFFERENTIATION OF REGULATORY T CELLS IN AML	2
Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia	2
3004 – ACUTE MYELOID LEUKEMIA CELLS REQUIRE 18-CARBON LONG FATTY ACIDS FOR PROTEIN S-ACYLATION TO MAINTAIN MITOCHONDRIAL ACTIVITY AND METABOLIC PLASTICITY	2
2022 – TRANSCRIPTION FACTOR REDISTRIBUTORS ACTUATE NON-CANONICAL GENE CIRCUITS TO DRIVE AML DIFFERENTIATION	2
3111 – BCL11B ORCHESTRATES GENERATION OF LYMPHOID-PRIMED DEFINITIVE HEMATOPOIETIC PROGENITORS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS	2
3179 – ID1 ABLATION RESCUES CLONAL HEMATOPOIESIS AND DELAYS DISEASE PROGRESSION IN TET2 NULL MICE	2
1029 – ETIOLOGY, PATHOGENESIS AND CELL-OF-ORIGIN OF MLL-REARRANGED INFANT/PEDIATRIC B-CELL ALL	2
Cohesin haploinsufficiency is tolerated in Cbfb::MYH11-driven murine acute myeloid leukemia	2
1012 – DEVELOPMENTAL PROGRAMMING OF TISSUE-RESIDENT MACROPHAGES	2
3095 – SEX-SPECIFIC DIFFERENCES IN PLATELET PARAMETERS AND THE UTILITY OF MEAN PLATELET VOLUME/ PLATELET COUNT RATIO IN DIAGNOSING IRON DEFICIENCY ANEMIA	2
3106 – PROTEOMICS AND GENOMICS STUDIES REVEALED A NEW ROLE FOR MLL PARTIAL TANDEM DUPLICATION (PTD) IN MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML)	2
1019 –	2
3099 – CYTOPLASMIC LOCALIZATION OF THE POLYCOMB PROTEIN CBX7 BLOCKS LEUKEMIC CELL GROWTH.	2
Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone	2
3202 – M. AVIUM INDUCES EPIGENETIC REPROGRAMMED HSPC-TRAINED IMMUNITY THAT ALTERS DOWNSTREAM MYELOID IMMUNE FUNCTION.	2
3023 – CHARACTERIZATION OF THE ONCOGENIC ACTIVITY OF TLX1 AND TLX3 TRANSCRIPTION COMPLEXES IN T-ALL	2
1022 – THE DEVELOPMENTAL ORIGINS OF BLOOD AND BLOOD CANCER	2
3150 – GATA2 DETERMINES HEMATOPOIETIC STEM/PROGENITOR CELL RESPONSES TO OPPORTUNISTIC FUNGAL INFECTION	2
Cover 2: Editorial Board	2
3089 – ERK INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS	2
1011 – MULTIPLEXING SPATIAL TRANSCRIPTOMICS, 4D IN SITU INTRAVITAL DATA AND 3D IMAGING TO DEFINE BONE MARROW MICROENVIRONMENTS IN INFLAMMATION AND BLOOD CANCER	2
2019 – ENDOTHELIAL CELL-DERIVED THROMBOSPONDIN-1 NEGATIVELY AFFECTS HEMATOPOIETIC FUNCTION DURING AGING	2
3047 – A NAD+ METABOLIC CHECKPOINT REGULATES HEMATOPOIETIC STEM CELL ACTIVATION AND AGING	2
3007 – T-CELL MEDIATED STEM-LIKE PLASTICITY OF GERMINAL CENTER B CELLS	2
3235 – HYPERDIPLOIDY IMPAIRS FETAL HSPC FITNESS AND DIFFERENTIATION ENABLING LONG-TERM PERSISTENCE OF RARE PRELEUKEMIC TRISOMIC CLONES IN BONE MARROW	2
3247 – A PROMISING PLANT ALKALOID PROVIDES NEUROPROTECTION AGAINST AΒ-INDUCED TOXICITY IN SH-SY5Y CELLS	2
Novel techniques to quantitatively assess age-dependent alterations in biophysical properties of HSPCs and bone marrow niche	2
3148 – EMP- AND HSC-DERIVED NEUTROPHILS DYNAMICALLY CONTRIBUTE TO THE DEVELOPING MOUSE HEMATOPOIETIC SYSTEM	2
Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cells	2
3200 – RENIN-ANGIOTENSIN SYSTEM INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS	2
3064 – AN ACTIVATED GPR56 RECEPTOR ENHANCES SURVIVAL OF HUMAN IPSC-DERIVED HAEMATOPOIETIC STEM/PROGENITOR CELLS	2
3158 – VENETOCLAX AND PROTEASOME INHIBITORS SYNERGISTICALLY INDUCE APOPTOSIS IN ACUTE MYELOID LEUKEMIA	2
Establishing a low-dose x-ray irradiation protocol for experimental acute graft-versus-host disease	2
3037 – POLYCOMB GROUP PROTEIN MEL18 REGULATES HEMATOPOIETIC STEM CELL BEHAVIORS VIA MODULATING THE EPIGENOME AND HIGHER ORDER CHROMATIN STRUCTURE	2
3126 – PERSISTENT METABOLIC DEFLATION OF HEMATOPOIETIC STEM CELLS (HSCS) AFTER CHEMOTHERAPY CAUSES PREMATURE HEMATOPOIETIC AGEING	1
Honoring giants in hematopoietic stem and progenitor cell biology	1
3104 – EARLY MOLECULAR STEPS IN HUMAN BONE MARROW STEM CELL DIFFERENTIATION TRAJECTORIES	1
3031 – DEFINING THE MESODERMAL ORIGINS OF THE HUMAN HEMATOPOIETIC PROGRAMS USING PLURIPOTENT STEM CELLS	1
3145 – WHAT IS THE FUNCTION OF THE EPO-EPOR AXIS IN MATURE XENOPUS ERYTHROCYTES?	1
The (intra-aortic) hematopoietic cluster cocktail: what is in the mix?	1
2001 – BLOOD FLOW TRIGGERS MTORC1-DEPENDENT MITOCHONDRIAL REMODELING REQUIRED FOR HEMATOPOIETIC STEM CELL FATE	1
2015 – STRUCTURAL AND FUNCTIONAL ANALYSIS OF BONE MARROW STROMAL NETWORKS DURING CHEMOTHERAPY	1
Metabolic regulation of erythrocyte development and disorders	1
IFC Editorial Board	1
3201 – MOLECULAR CHARACTERISTICS OF MALIGNANT HEMATOPOIETIC STEM CELLS IN ESSENTIAL THROMBOCYTHEMIA ACROSS DISTINCT DRIVER MUTATIONS	1
3044 – CRISPR ACTIVATION SCREENS IDENTIFY CO-DRIVERS OF MALIGNANT HAEMATOPOIESIS IN A DNMT3A MUTANT BACKGROUND	1
Balancing hematopoietic stem cell self-renewal and differentiation activities throughout ontogeny and aging	1
3248 – LARGE-SCALE PRODUCTION OF TRANSFUSION-READY CULTURED RED BLOOD CELLS FROM INDUCED PLURIPOTENT STEM CELLS	1
3090 – HEMATOPOIETIC STEM AND PROGENITOR CELL VESICLES PRE-CONDITION THE BONE MARROW NICHE DURING TRANSPLANTATION	1
3221 – NFAT TRANSCRIPTION FACTORS ARE REQUIRED FOR DEFINITIVE HEMATOPOIESIS	1
Peposertib suppresses generation of FLT3-internal tandem duplication formed by contralateral double nicks	1
3038 – SCIMP PROMOTES TLR SIGNALING AND REGULATES FUNCTION IN HEMATOPOIETIC STEM CELLS	1
3086 – APOPTOTIC CELLS-DERIVED CD14(+) MICROPARTICLES PROMOTE THE PHAGOCYTIC ACTIVITY OF NEUTROPHILIC PRECURSOR CELLS IN THE PHAGOCYTOSIS OF APOPTOTIC CELLS	1
IFC Editorial Board	1
3118 – CHAPERONE-MEDIATED AUTOPHAGY MAINTAINS LEUKEMIC STEM CELLS	1
A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs	1
3043 – SEX-DEPENDENT NICHE RESPONSES MODULATE STEADY-STATE AND REGENERATIVE HEMATOPOIESIS	1
3195 – FISH IN COMBINATION WITH RT-PCR AIDS IN THE CLASSIFICATION OF B-OTHER ALL BY IMPROVING THE IDENTIFICATION OF THE ZNF384 REARRANGEMENT	1
Cis- and trans-regulation of Irf8 enhancers during dendritic cell development	1
3140 – A TÊTE-À-TÊTE ABOUT TRISOMY 21: ELUCIDATING HOW PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IMPACTS CLONAL HEMATOPOIESIS	1
2024 – SPATIAL TRANSCRIPTOMICS CHARACTERIZE DYNAMIC AND POLARIZED NICHE CELLS AND SIGNALS FOR EMBRYONIC HEMATOPOIESIS	1
3009 – BLOOD-RESIDENT MACROPHAGES (BMΦ) SAFEGUARD BLOOD AND VESSEL INTEGRITY	1
2001 – EMBRYONIC MACROPHAGES REGULATE THE SIZE OF THE DEFINITIVE HSC POOL	1
3005 – DIFFERENTIATION, AGING, AND LEUKEMIA ALTER THE METABOLIC PROFILE OF HUMAN BONE MARROW HEMATOPOIETIC STEM AND PROGENITOR CELLS	1
3103 – INHIBITING MAST CELL FUNCTION TO PROMOTE HEMATOPOIETIC REGENERATION FOLLOWING INJURY	1
3047 – ROLE OF EPIGENETIC DYSFUNCTION IN CHRONIC NEUTROPHILIC LEUKEMIA	1
3143 – ACUTE HEMATOPOIETIC RESPONSE OF GRANULOCYTE COLONY-STIMULATING FACTOR EXPRESSION IN MEDAKA FISH	1
3015 – COORDINATED REGULATION AT THE SYSTEMIC AND LOCAL LEVELS PLAYS A PIVOTAL ROLE IN DETERMINING HEMATOPOIETIC STEM CELL NUMBERS	1
3175 – AN UNSUPERVISED INTEGRATION FRAMEWORK TO COMPREHENSIVELY CAPTURE HUMAN HEMATOPOIETIC STEM CELL VARIATION IDENTIFIES HALLMARK SIGNATURES WITH A LINK TO AGING	1
Lethal and sublethal effects of programmed cell death pathways on hematopoietic stem cells	1
Harnessing the potential of gene-editing technology to overcome the current bottlenecks of CAR-T cell therapy in T-cell malignancies	1
3062 – HIGH THROUGHPUT EPIGENOMIC PROFILING IN HEMATOPOIETIC STEM/PROGENITOR FATE COMMITMENT	1
2020 – PRECISE SINGLE-CELL TRANSCRIPTOMIC MAPPING OF NORMAL AND LEUKEMIC CELL STATES REVEALS UNCONVENTIONAL LINEAGE PRIMING IN ACUTE MYELOID LEUKEMIA	1
Sex differences alter primitive progenitors in the C57BL/6 Tet2 knockout mouse model	1
3200 – DEVELOPMENTAL REGULATION OF ENDOTHELIAL-TO-HEMATOPOIETIC TRANSITION FROM INDUCED PLURIPOTENT STEM CELLS	1
3002 – TRANSCRIPTION FACTOR PROFILING REVEALS THAT CEBPA PROMOTES RIBOSOMAL RNA SYNTHESIS IN MYELOID PROGENITORS	1
3183 – PROGRESSIVE IMBALANCE BETWEEN CLU⁺ AND CLU− HSCs DRIVES FUNCTIONAL HEMATOPOIETIC AGING	1
3012 – IL-27 REGULATES MONOCYTE DEVELOPMENT AND FUNCTION DURING ACUTE TOXOPLASMA GONDII INFECTION	1
D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1	1